International Flavors & Fragrances IFF Health & Biosciences — Research and development expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by International Flavors & Fragrances in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: International Flavors & Fragrances’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about International Flavors & Fragrances's health & biosciences — research and development expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is International Flavors & Fragrances's health & biosciences — research and development expenses?
- International Flavors & Fragrances (IFF) reported health & biosciences — research and development expenses of $55M in Q1 2026.
- How has International Flavors & Fragrances's health & biosciences — research and development expenses changed year-over-year?
- International Flavors & Fragrances's health & biosciences — research and development expenses increased by 5.8% year-over-year, from $52M to $55M.
- What is the long-term trend for International Flavors & Fragrances's health & biosciences — research and development expenses?
- Over 3 years (2022 to 2025), International Flavors & Fragrances's health & biosciences — research and development expenses has grown at a 9.7% compound annual growth rate (CAGR), from $166M to $219M.
- What does health & biosciences — research and development expenses mean?
- Expenditures dedicated to the discovery, development, and improvement of proprietary formulations and specialty ingredients within the Health & Biosciences segment. This investment is critical for maintaining a competitive advantage through innovation.